Physician

Jeffrey Parker Rowand, MD

According to 2025 Medicare claims, Jeffrey Rowand, MD (NPI: 1245523034) practices family practice in the York-Hanover, PA market, with the plurality of this provider's patient population coming from York, PA. This provider's primary affiliated billing organization is DALLASTOWN MEDICAL ASSOCIATES LLP (NPI: 1003881186; TIN: 232109447) and primary practice location at 17313-9220. Rowand is affiliated with the WellSpan Population Health Services (ACO ID: A2500), participating under the MSSP model.

Rowand's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 375 traditional Medicare patients, billed 13,003 HCPCS/CPT codes, and received $271,166 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 11,962 prescription claims across 775 beneficiaries totaling $1,517,097 in drug costs, led by Eliquis (Apixaban). DME data shows 416 claims. Open Payments data shows 94 records totaling $1,717. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $110,061 to $271,166. Similarly, Part D prescription costs have moved sharply higher in recent years, from $210,318 to $1,517,097. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $3,724 to $27,479.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$136K$271K2015 Medicare payment: $110,061 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $140,239 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $134,728 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $156,251 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $158,997 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $166,323 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $220,117 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $225,797 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $241,715 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $271,166 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20153554,548$110,061
20163566,330$140,239
20173476,995$134,728
20183377,563$156,251
20193188,312$158,997
20203619,569$166,323
202157712,151$220,117
202240512,645$225,797
202340411,592$241,715
202437513,003$271,166

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$759K$1.5M2015 Drug cost: $210,318 (USD; Tot_Drug_Cst)2016 Drug cost: $447,523 (USD; Tot_Drug_Cst)2017 Drug cost: $473,223 (USD; Tot_Drug_Cst)2018 Drug cost: $536,287 (USD; Tot_Drug_Cst)2019 Drug cost: $690,252 (USD; Tot_Drug_Cst)2020 Drug cost: $922,771 (USD; Tot_Drug_Cst)2021 Drug cost: $1,076,576 (USD; Tot_Drug_Cst)2022 Drug cost: $1,228,406 (USD; Tot_Drug_Cst)2023 Drug cost: $1,439,562 (USD; Tot_Drug_Cst)2024 Drug cost: $1,517,097 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154313,247$210,318
20164616,054$447,523
20174856,611$473,223
20184606,959$536,287
20194727,388$690,252
20205938,847$922,771
20216299,686$1,076,576
202270010,272$1,228,406
202377211,015$1,439,562
202477511,962$1,517,097

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$12K$24K2015 Medicare payment: $2,618 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $4,161 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $3,071 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $7,219 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $5,134 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $4,981 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $8,035 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $9,011 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $19,647 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $24,457 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R41$2,618
2016N/R150$4,161
201712140$3,071
201825293$7,219
201912191$5,134
202012155$4,981
202129214$8,035
202238306$9,011
202344407$19,647
202471416$24,457

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more262701$80
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's282669$11
36415Insertion of needle into vein for collection of blood sample264598$6
82565Blood creatinine level244502$5
82435Blood chloride level244498$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EliquisApixaban33518,211$342,851
JardianceEmpagliflozin906,330$118,809
Trelegy ElliptaFluticasone/Umeclidin/Vilanter1155,220$108,222
OzempicSemaglutide462,156$66,876
MounjaroTirzepatide451,764$63,992

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
A4239Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of serviceNN/R33$12,445
A7030Full face mask used with positive airway pressure device, eachNN/R24$1,907
A7031Face mask interface, replacement for full face mask, eachNN/R23$1,829
E1390Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rateYN/R22$1,278
A7033Pillow for use on nasal cannula type interface, replacement only, pairNN/R15$1,199

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.94$1,717GlaxoSmithKline, LLC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jeffrey Parker Rowand, MD?

Tedicare shows public-source Medicare data for Jeffrey Parker Rowand, MD (NPI 1245523034), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jeffrey Parker Rowand, MD have ACO affiliation data?

Jeffrey Parker Rowand, MD is shown with ACO affiliation data for WellSpan Population Health Services (MSSP, ACO ID A2500).

What billing organization is linked to Jeffrey Parker Rowand, MD?

Jeffrey Parker Rowand, MD is linked to DALLASTOWN MEDICAL ASSOCIATES LLP (billing NPI 1003881186) in the available physician profile data.

Does Jeffrey Parker Rowand, MD have Open Payments data?

Jeffrey Parker Rowand, MD has 94 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.